On September 2, Geelong reported that as of August 31, 2024, the company has repurchased a total of 5,600,767 shares through the Shenzhen Stock Exchange trading system through centralized bidding trading, accounting for 0.93% of the company's current total share capital. The highest transaction price was 18.52 yuan/share, the lowest transaction price was 16.23 yuan/share, and the total transaction amount was 99.1311 million yuan (excluding transaction costs). The implementation of the repurchase meets the requirements of relevant laws and regulations and complies with the company's established repurchase plan.
华兰疫苗(301207.SZ)：累计已回购0.93%股份
Hualan Vaccine (301207.SZ): cumulative repurchased 0.93% of shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.